Phage identification tool shortens the search for specific viruses to combat dangerous bacteria
A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...
ExtremeTech on MSN5d
Scientists Identify Antibodies That Neutralize the Virus Behind COVID-19
The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...
CeSPIACE: A broad spectrum peptide inhibitor against variable SARS-CoV-2 spikes
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
New Antibody Therapy Shows Promise Against All COVID Variants – And the Future Ones Too
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
Boston College7d
Predicting the future of COVID-19
“We computationally predict what mutations allow better binding to host receptors and better evasion of antibodies,” said Boston College Assistant Professor of Biology Babak Momeni, a lead researcher ...
News-Medical.Net1h
Novel cyclic peptide antagonist can be a promising therapeutic approach for MASH
The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.
Pharmabiz11d
Androgen receptor non-canonical domain binding degrader for treatment of relapsed, refractory castration-resistant prostate cancer
K. Sadasivan Pillai Wednesday, March 5, 2025, 08:00 Hrs [IST] ...
Medscape2d
Tocilizumab: The First Interleukin-6-Receptor Inhibitor
Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL-6R). Inhibiting the entire receptor complex prevents IL-6 ...